Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement

Common Size IS
Op Efficiency
Credit Analysis

IMPEL PHARMACEUTICALS INC (IMPL)

Cash Flow Statement

Standardized | As Reported Annual | Quarterly | TTM
 
In millions, except per share itemsDec-31-22Dec-05-22Dec-31-21Dec-05-21Dec-31-20Dec-05-20Dec-31-19
   10-K8-K10-K8-K10-K8-KS-1
Net income  -106.3-106.3-76.7-76.7-46.3-46.3-42.4
Depreciation and amortization  1.2 1.1 1.1 0.7
Asset impairment charges  0.1 0.2    
Stock-based compensation  5.2 3.1 3.6 0.8
Change in working capital   [+]14.0 23.8 1.7 2.9
Other operating activities  -7.9 -17.9 0.7 1.5
Cash from operations  -93.6 -66.4 -39.2 -36.5
   
Capital expenditures  -1.4 -0.4 -1.8 -1.5
Cash from investing  -1.4 -0.4 -1.8 -1.5
   
Issuance of common stock, net  4.3 120.3    
Option exercises  0.2 0.8 0.9 0.0
Other cash from financing  63.4 28.4 11.9 0.0
Cash from financing  67.5 147.9 11.1 0.0
   
Free cash flow  -95.0 -66.8 -41.0 -38.0
        Per share (diluted)  ($4.05) ($4.57) ($80.53) ($109.53)
   
Cash paid for interest  4.6 1.4 0.1  

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy